Malignant sublingual gland tumors: A single‐center retrospective analysis of 79 patients
Oral Diseases · 2024
DOI: 10.1111/odi.14538 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Diseases, 2024. Verfasst von Yifan Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial-Head and Neck Oncology, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University …. Hauptthemen laut MEDLINE: Sublingual Gland Neoplasms, Lymphatic Metastasis, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Research Grants (20204Y0456) from the Shanghai Municipal Health Commission, Research Grants (22Y11903300) from the Science and Technology Commission of Shanghai Municipality, Shanghai Sailing Program (21YF1423500, 20YF1423300).
Abstract (Originalsprache)
Objectives
To analyze and summarize the clinicopathological features, risk factors for cervical nodal metastasis, and prognostic factors of malignant sublingual gland tumors (MSLGT).
Methods
Patients diagnosed with MSLGT were retrospectively reviewed from January 2005 to December 2017 at Shanghai Ninth Hospital. The clinicopathological features were summarized, and the correlations between clinicopathological parameters, cervical nodal metastasis, and local–regional recurrence were evaluated using the Chi‐square test. Kaplan–Meier method and Cox regression analysis were performed to assess the survival and independent prognostic factors.
Results
Seventy‐nine patients were included, and the 5‐year overall survival and disease‐free survival rates was 85.7% and 71.7%, respectively. Gender and clinical tumor stage were risk factors for cervical nodal metastasis. Tumor size and pathological lymph node (LN) stage were independent prognostic factors for adenoid cystic carcinoma (ACC) of the sublingual gland; while age, pathological LN stage, and distant metastasis were prognostic factors for patients with non‐ACC of the sublingual gland. Patients with higher clinical stage were more likely to undergo tumor recurrence.
Conclusions
Malignant sublingual gland tumors are rare, and neck dissection should be performed in male MSLGT patients with higher clinical stage. Among patients with both ACC and non‐ACC MSLGT patients, pN+ indicate a poor prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial-Head and Neck Oncology, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine; National Clinical Research Center for Oral Disease…
- Department of Oral Pathology, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
ORCID-Profile: Wanlin Xu, Wenjun Yang
Förderung
- Research Grants (20204Y0456) from the Shanghai Municipal Health Commission
- Research Grants (22Y11903300) from the Science and Technology Commission of Shanghai Municipality
- Shanghai Sailing Program (21YF1423500, 20YF1423300)
Zitieren
APA
Wu, Y., Lu, H., Liu, L., Zhu, Y., Zhang, X., Xu, W., Liu, S., & Yang, W. (2024). Malignant sublingual gland tumors: A single‐center retrospective analysis of 79 patients. Oral Diseases. https://doi.org/10.1111/odi.14538
Vancouver
Wu Y, Lu H, Liu L, Zhu Y, Zhang X, Xu W, et al. Malignant sublingual gland tumors: A single‐center retrospective analysis of 79 patients. Oral Diseases. 2024. doi:10.1111/odi.14538
BibTeX
@article{Wu2024,
author = {Wu, Yifan and Lu, Hao and Liu, Limin and Zhu, Yun and Zhang, Xu and Xu, Wanlin and Liu, Shengwen and Yang, Wenjun},
title = {Malignant sublingual gland tumors: A single‐center retrospective analysis of 79 patients},
journal = {Oral Diseases},
year = {2024},
doi = {10.1111/odi.14538}
}
EUVIMED